IL33 and eosinophilic esophagitis: In patients with EoE, IL‐33 is overexpressed on the esophageal epithelium [14] while its receptor suppression of tumorigenicity 2 (ST2) is frequently exposed on the surface of esophageal‐infiltrating eosinophils [15].